Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 34% ± 13% | |
peripheral blood | 16 studies | 37% ± 11% | |
intestine | 11 studies | 27% ± 12% | |
liver | 8 studies | 32% ± 22% | |
kidney | 7 studies | 28% ± 8% | |
brain | 6 studies | 25% ± 5% | |
bone marrow | 5 studies | 30% ± 10% | |
eye | 5 studies | 27% ± 9% | |
lymph node | 5 studies | 36% ± 11% | |
pancreas | 4 studies | 37% ± 11% | |
uterus | 4 studies | 41% ± 14% | |
breast | 4 studies | 32% ± 7% | |
placenta | 3 studies | 44% ± 5% | |
skin | 3 studies | 40% ± 12% | |
prostate | 3 studies | 35% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4984.60 | 258 / 258 | 100% | 70.21 | 230 / 230 |
bladder | 100% | 6018.81 | 21 / 21 | 100% | 126.83 | 504 / 504 |
esophagus | 100% | 7089.31 | 1445 / 1445 | 100% | 103.95 | 183 / 183 |
intestine | 100% | 5893.41 | 966 / 966 | 100% | 127.80 | 527 / 527 |
lung | 100% | 5594.55 | 578 / 578 | 100% | 90.80 | 1155 / 1155 |
ovary | 100% | 5190.05 | 180 / 180 | 100% | 117.65 | 430 / 430 |
skin | 100% | 10069.39 | 1809 / 1809 | 100% | 115.91 | 472 / 472 |
stomach | 100% | 4713.91 | 359 / 359 | 100% | 113.60 | 286 / 286 |
thymus | 100% | 4815.08 | 653 / 653 | 100% | 79.15 | 605 / 605 |
uterus | 100% | 5402.94 | 170 / 170 | 100% | 134.21 | 459 / 459 |
prostate | 100% | 4704.61 | 245 / 245 | 100% | 82.80 | 501 / 502 |
kidney | 100% | 4213.58 | 89 / 89 | 100% | 64.31 | 899 / 901 |
breast | 100% | 6112.53 | 459 / 459 | 100% | 96.70 | 1115 / 1118 |
liver | 100% | 3210.77 | 225 / 226 | 100% | 61.59 | 406 / 406 |
brain | 99% | 3938.81 | 2624 / 2642 | 100% | 80.63 | 705 / 705 |
pancreas | 99% | 3889.00 | 325 / 328 | 99% | 73.39 | 177 / 178 |
adipose | 100% | 6514.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5766.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 101.93 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 147.93 | 29 / 29 |
muscle | 100% | 7154.98 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5417.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 126.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 93.76 | 1 / 1 |
peripheral blood | 99% | 6562.39 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 4285.85 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006364 | Biological process | rRNA processing |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006417 | Biological process | regulation of translation |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005730 | Cellular component | nucleolus |
GO_0070062 | Cellular component | extracellular exosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PA2G4 |
Protein name | Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1) Proliferation-associated 2G4 PA2G4 protein |
Synonyms | EBP1 |
Description | FUNCTION: May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly. Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site) (By similarity). Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). . |
Accessions | Q05D08 Q6PIN5 Q9UQ80 F8VR77 ENST00000303305.11 [Q9UQ80-1] ENST00000553057.5 ENST00000551061.1 ENST00000552766.5 F8VZ69 F8W0A3 |